{"id":"https://openalex.org/W2467707886","doi":null,"title":"Antifungal therapy for febrile neutropenia: issues in clinical trial design.","display_name":"Antifungal therapy for febrile neutropenia: issues in clinical trial design.","alternate_titles":[],"publication_year":2004,"publication_date":"2004-02-01","ids":{"openalex":"https://openalex.org/W2467707886","mag":"2467707886","pmid":"https://pubmed.ncbi.nlm.nih.gov/15043395"},"language":"en","primary_location":{"id":"pmid:15043395","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15043395","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2467707886"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067942412","display_name":"Kieren A. Marr","orcid":"https://orcid.org/0000-0002-1051-0376","observed_orcids":["https://orcid.org/0000-0002-1051-0376"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kieren A Marr","raw_affiliation_strings":["Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N D3-100, Seattle, WA 98119, USA. kmarr@fhcrc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N D3-100, Seattle, WA 98119, USA. kmarr@fhcrc.org","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067942412"],"corresponding_institution_ids":["https://openalex.org/I4210089486"],"apc_list":null,"apc_paid":null,"fwci":0.3853,"has_fulltext":false,"cited_by_count":6,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.61661732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"5","issue":"2","first_page":"202","last_page":"207"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.21080000698566437,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antifungal-therapy","display_name":"antifungal therapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":0.8830000162124634},{"id":"https://openalex.org/keywords/empiric-antifungal-therapy","display_name":"empirical antifungal therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8230000138282776},{"id":"https://openalex.org/keywords/inclusion-criteria","display_name":"inclusion criteria","score":0.8080000281333923},{"id":"https://openalex.org/keywords/antifungal-drug-development","display_name":"antifungal drug development","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7893311977386475},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7253986597061157},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7227506637573242},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6153361797332764},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5443300008773804},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.5397987365722656},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43174561858177185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2632909417152405},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14075925946235657},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0920080840587616}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:15043395","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15043395","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2058995582","https://openalex.org/W2110643478","https://openalex.org/W2118523395","https://openalex.org/W2099941297","https://openalex.org/W95850256","https://openalex.org/W7098808461","https://openalex.org/W4237370874","https://openalex.org/W2070673176","https://openalex.org/W2028197004","https://openalex.org/W2090373867"],"abstract_inverted_index":{"Amphotericin":[0],"B":[1],"therapy":[2],"for":[3,36,90],"fever":[4,93],"during":[5,94],"neutropenia":[6,18],"became":[7],"a":[8,22],"standard":[9],"practice":[10],"approximately":[11],"20":[12],"years":[13],"ago.":[14],"Treatment":[15],"of":[16,29,43,63,68,92],"febrile":[17],"has":[19],"since":[20],"become":[21],"common":[23],"indication":[24],"sought":[25],"in":[26,53,73],"the":[27,41,61,81],"development":[28],"new":[30,86],"antifungals,":[31],"with":[32],"several":[33],"alternatives":[34],"approved":[35],"'empirical":[37],"therapy'":[38],"based":[39],"on":[40],"results":[42],"randomized":[44],"clinical":[45],"trials.":[46],"Recent":[47],"studies":[48],"have":[49],"highlighted":[50],"problematic":[51],"issues":[52,72],"trial":[54,74],"design":[55,75],"and":[56,60],"interpretation;":[57],"inclusion":[58],"criteria":[59],"definition":[62],"success":[64],"are":[65],"two":[66],"examples":[67],"controversial":[69],"issues.":[70],"Here,":[71],"will":[76],"be":[77,88],"reviewed":[78],"to":[79],"address":[80],"question:":[82],"Can":[83],"(and":[84],"should)":[85],"antifungals":[87],"evaluated":[89],"treatment":[91],"neutropenia?":[95]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2467707886","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-07-22T00:00:00"}
